Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 2/2012

01.03.2012 | Clinical Investigation

Progression detection in different stages of glaucoma: mean deviation versus visual field index

verfasst von: Jung Woo Cho, Kyung Rim Sung, Sung-Cheol Yun, Jung Hwa Na, Youngrok Lee, Michael S. Kook

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We evaluated and compared visual field index (VFI) and mean deviation (MD) capacity in detecting glaucoma progression at different stages.

Methods

Participants were classified as having early-, moderate-, or advanced-stage glaucoma. Trend-based approaches (TA) using linear regression analysis of the VFI and MD (VFI TA, MD TA) over patient age were performed. The rate was determined by both approaches at different stages of glaucoma.

Results

We analyzed 173 eyes of 173 participants (mean follow-up 6.2 years). Glaucoma progressed in 24 eyes (13.9%) as determined by VFI TA and in 21 eyes (12.1%) as determined by MD TA. Agreement between VFI TA and MD TA was moderate to good (κ = 0.617). The rate was −0.29 ± 2.31 dB per year as determined by MD TA and 1.25 ± 4.79% per year as determined by VFI TA. Progression rate according to glaucoma severity was not significantly different among subgroups when assessed by both trend-based approaches.

Conclusion

VFI TA and MD TA performed similarly in measuring different stages of glaucoma progression. However, VFI TA and MD TA did not have agree perfectly in glaucoma progression detection. As glaucomatous changes can be general or localized, we suggest that changes in the MD and VFI should be considered when monitoring glaucoma progression through all stages.
Literatur
1.
Zurück zum Zitat Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453–64.PubMedCrossRef Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453–64.PubMedCrossRef
2.
Zurück zum Zitat Heijl A, Lindgren A, Lindgren G. Test–retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108:130–5.PubMed Heijl A, Lindgren A, Lindgren G. Test–retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108:130–5.PubMed
3.
Zurück zum Zitat Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, Crabb DP. Analysis of visual field progression in glaucoma. Br J Ophthalmol. 1996;80:40–8.PubMedCrossRef Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, Crabb DP. Analysis of visual field progression in glaucoma. Br J Ophthalmol. 1996;80:40–8.PubMedCrossRef
4.
Zurück zum Zitat Bengtsson B, Lindgren A, Heijl A, Lindgren G, Asman P, Patella M. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand. 1997;75:184–8.PubMedCrossRef Bengtsson B, Lindgren A, Heijl A, Lindgren G, Asman P, Patella M. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand. 1997;75:184–8.PubMedCrossRef
5.
Zurück zum Zitat Gardiner SK, Crabb DP. Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci. 2002;43:1400–7.PubMed Gardiner SK, Crabb DP. Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci. 2002;43:1400–7.PubMed
6.
Zurück zum Zitat Advanced Glaucoma Intervention Study. 2: visual field test scoring and reliability. Ophthalmology. 1994;101:1445–55. Advanced Glaucoma Intervention Study. 2: visual field test scoring and reliability. Ophthalmology. 1994;101:1445–55.
7.
Zurück zum Zitat Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653–62.PubMedCrossRef Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653–62.PubMedCrossRef
8.
Zurück zum Zitat Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487–97.CrossRef Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487–97.CrossRef
9.
Zurück zum Zitat Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology. 1999;106:2144–53.PubMedCrossRef Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology. 1999;106:2144–53.PubMedCrossRef
10.
Zurück zum Zitat Bebie H. Computerized techniques of visual field analysis. In: Drance SM, Anderson D, editors. Automatic perimetry in glaucoma. Orlando: Grune and Stratton; 1985. p. 147–60. Bebie H. Computerized techniques of visual field analysis. In: Drance SM, Anderson D, editors. Automatic perimetry in glaucoma. Orlando: Grune and Stratton; 1985. p. 147–60.
11.
Zurück zum Zitat Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. Doc Ophthalmol Proc Ser. 1987;49:153–68.CrossRef Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. Doc Ophthalmol Proc Ser. 1987;49:153–68.CrossRef
12.
Zurück zum Zitat Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145:343–53.PubMedCrossRef Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145:343–53.PubMedCrossRef
13.
Zurück zum Zitat Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St Louis: Mosby; 1993. p. 53. Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St Louis: Mosby; 1993. p. 53.
14.
Zurück zum Zitat Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24–30.PubMedCrossRef Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24–30.PubMedCrossRef
15.
Zurück zum Zitat Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC. Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci. 2005;46:4600–6.PubMedCrossRef Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC. Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci. 2005;46:4600–6.PubMedCrossRef
16.
Zurück zum Zitat Casas-Llera P, Rebolleda G, Muñoz-Negrete FJ, Arnalich-Montiel F, Pérez-López M, Fernández-Buenaga R. Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population. Br J Ophthalmol. 2009;93:1576–9.PubMedCrossRef Casas-Llera P, Rebolleda G, Muñoz-Negrete FJ, Arnalich-Montiel F, Pérez-López M, Fernández-Buenaga R. Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population. Br J Ophthalmol. 2009;93:1576–9.PubMedCrossRef
17.
Zurück zum Zitat Anderson DR, Drance SM, Schulzer M, Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108:247–53.PubMedCrossRef Anderson DR, Drance SM, Schulzer M, Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108:247–53.PubMedCrossRef
18.
Zurück zum Zitat Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal–tension glaucoma. Am J Ophthalmol. 2001;131:699–708.PubMedCrossRef Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal–tension glaucoma. Am J Ophthalmol. 2001;131:699–708.PubMedCrossRef
19.
Zurück zum Zitat Heijl A, Bengtsson B, Hyman L, Leske MC, Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma. Ophthalmology. 2009;116:2271–6.PubMedCrossRef Heijl A, Bengtsson B, Hyman L, Leske MC, Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma. Ophthalmology. 2009;116:2271–6.PubMedCrossRef
20.
Zurück zum Zitat Ahrlich K, De Moraes CG, Teng CC, Prata TS, Tello C, Ritch R, et al. Visual field progression difference between normal-tension and exfoliative high-tension glaucoma patients. Invest Ophthalmol Vis Sci. 2010;51:1458–63.PubMedCrossRef Ahrlich K, De Moraes CG, Teng CC, Prata TS, Tello C, Ritch R, et al. Visual field progression difference between normal-tension and exfoliative high-tension glaucoma patients. Invest Ophthalmol Vis Sci. 2010;51:1458–63.PubMedCrossRef
21.
Zurück zum Zitat Bengtsson B, Patella VM, Heijl A. Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol. 2009;127:1610–5.PubMedCrossRef Bengtsson B, Patella VM, Heijl A. Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol. 2009;127:1610–5.PubMedCrossRef
Metadaten
Titel
Progression detection in different stages of glaucoma: mean deviation versus visual field index
verfasst von
Jung Woo Cho
Kyung Rim Sung
Sung-Cheol Yun
Jung Hwa Na
Youngrok Lee
Michael S. Kook
Publikationsdatum
01.03.2012
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 2/2012
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-011-0110-7

Weitere Artikel der Ausgabe 2/2012

Japanese Journal of Ophthalmology 2/2012 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.